Stock listing
VYGR Stock Price, News, Filings & Events — Voyager Therapeutics, Inc.
Selected listing: VYGR · BMV · MXN · MX
This page tracks Voyager Therapeutics, Inc.'s VYGR:BMV listing on BMV in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VYGR:BMV. VYGR:BMV is the stock-level entry point for investors researching Voyager Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Voyager Therapeutics, Inc. is a public company traded under the ticker VYGR in the American market. The company has a market capitalization of approximately $191.5 million. Voyager Therapeutics focuses on developing gene therapies for neurological diseases.
- Ticker
- VYGR:BMV
- Asset type
- Stock
- Market cap
- $190.4M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BMV
- Currency
- MXN
Voyager Therapeutics, Inc. VYGR:BMV stock context
This page tracks Voyager Therapeutics, Inc.'s VYGR:BMV listing on BMV in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VYGR:BMV. VYGR:BMV is the stock-level entry point for investors researching Voyager Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Voyager Therapeutics, Inc. is a public company traded under the ticker VYGR in the American market. The company has a market capitalization of approximately $191.5 million. Voyager Therapeutics focuses on developing gene therapies for neurological diseases.
Latest news from Voyager Therapeutics, Inc.
Voyager Technologies, Inc. Announces Proposed Convertible Senior Notes Offering
September 22, 2026
Voyager Demonstrates Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 6-Month GLP Toxicology Study; Initiation of Clinical Trial in Alzheimer’s Disease Expected H2 2026
July 13, 2026
Voyager’s Tau-Targeted Gene Therapy VY1706 for Alzheimer’s Disease to Be Featured in Developing Topics Poster Presentation at AAIC 2026
June 29, 2026
Voyager to Present at H.C. Wainwright 7th Annual Neuro Perspectives Hybrid Conference
June 11, 2026
Voyager Receives FDA IND Clearance for VY1706, First Gene Therapy Approach to Reducing Tau Production in the Brain for Alzheimer’s Disease
June 1, 2026
Voyager Therapeutics, Inc. earnings calls
Voyager Therapeutics, Inc. (VYGR) Q3 2025 Earnings Call
November 11, 2025 · Replay with transcript and chapters
Voyager Therapeutics, Inc. (VYGR) Q2 2025 Earnings Call
August 12, 2025 · Replay with transcript and chapters
Voyager Therapeutics, Inc. (VYGR) Q1 2025 Earnings Call
May 13, 2025 · Replay with transcript and chapters
Voyager Therapeutics, Inc. (VYGR) Q4 2024 Earnings Call
March 11, 2025 · Replay with transcript and chapters
Voyager Therapeutics, Inc. (VYGR) Q3 2024 Earnings Call
November 12, 2024 · Replay with transcript and chapters
Voyager Therapeutics, Inc. (VYGR) Q2 2024 Earnings Call
August 6, 2024 · Replay with transcript and chapters
Research Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for VYGR:BMV.
Voyager Therapeutics, Inc. company profile
View the public company page for Voyager Therapeutics, Inc. on 6ix.
Voyager Therapeutics, Inc. news
Read company news and market updates connected to Voyager Therapeutics, Inc..
Voyager Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Voyager Therapeutics, Inc..
Alternate listings
VYGR:NASDAQ
US · USD
Alternate listing for Voyager Therapeutics, Inc.; the primary context on this page is VYGR:BMV.
VT6:TRADEGATE
DE · EUR
Alternate listing for Voyager Therapeutics, Inc.; the primary context on this page is VYGR:BMV.
VT6:GETTEX
DE · EUR
Alternate listing for Voyager Therapeutics, Inc.; the primary context on this page is VYGR:BMV.
A143XJ:LSX
DE · EUR
Alternate listing for Voyager Therapeutics, Inc.; the primary context on this page is VYGR:BMV.
A143XJ:LS
DE · EUR
Alternate listing for Voyager Therapeutics, Inc.; the primary context on this page is VYGR:BMV.
VT6:FWB
DE · EUR
Alternate listing for Voyager Therapeutics, Inc.; the primary context on this page is VYGR:BMV.
VYGR:BIVA
MX · MXN
Alternate listing for Voyager Therapeutics, Inc.; the primary context on this page is VYGR:BMV.
VYGR:BOATS
US · USD
Alternate listing for Voyager Therapeutics, Inc.; the primary context on this page is VYGR:BMV.
VT6:DUS
DE · EUR
Alternate listing for Voyager Therapeutics, Inc.; the primary context on this page is VYGR:BMV.
VT6:HAM
DE · EUR
Alternate listing for Voyager Therapeutics, Inc.; the primary context on this page is VYGR:BMV.
VT6:MUN
DE · EUR
Alternate listing for Voyager Therapeutics, Inc.; the primary context on this page is VYGR:BMV.
VT6:SWB
DE · EUR
Alternate listing for Voyager Therapeutics, Inc.; the primary context on this page is VYGR:BMV.